Year archive

Active Biotech — 2015 filings

All 40 regulatory filings released by Active Biotech (ACTI) in 2015, sourced directly from the official regulator.

40 Filings

2015 Period

2015 filings (40)

Filing	Released	Lang
Active Biotech's election committee appointed AGM Information	2015-11-23	English
Active Biotechs valberedning utsedd AGM Information	2015-11-23	Swedish
Interim / Quarterly Report 2015 Interim / Quarterly Report 9M 2015	2015-11-06	Swedish
Interim / Quarterly Report 2015 Interim / Quarterly Report 9M 2015	2015-11-06	English
Active Biotech AB Delårsrapport januari - september 2015 Interim / Quarterly Report 9M 2015	2015-11-06	Swedish
Active Biotech AB Interim report January - September 2015 Interim / Quarterly Report 9M 2015	2015-11-06	English
Active Biotechs partner Teva presenterar data för laquinimod mot multipel skleros på den vetenskapliga konferensen ECTRIMS Regulatory Filings	2015-10-06	Swedish
Active Biotech's partner Teva presents data on laquinimod for the treatment of multiple sclerosis at 31st ECTRIMS Congress Regulatory Filings	2015-10-06	English
Final results from Active Biotech's 10TASQ10 Phase 3 study of tasquinimod presented at the ECC conference Regulatory Filings	2015-09-28	English
Finala resultat från Active Biotechs tasquinimod fas 3-studie 10TASQ10 presenteras på konferensen ECC Regulatory Filings	2015-09-28	Swedish
Interim / Quarterly Report 2015 Interim / Quarterly Report H1 2015	2015-08-07	Swedish
Interim / Quarterly Report 2015 Interim / Quarterly Report H1 2015	2015-08-07	English
Active Biotech AB Delårsrapport januari - juni 2015 Interim / Quarterly Report H1 2015	2015-08-07	Swedish
Active Biotech AB Interim report January - June 2015 Interim / Quarterly Report H1 2015	2015-08-07	English
Teva and Active Biotech Announce Completion of Patient Enrollment in Laquinimod Phase III CONCERTO Trial Regulatory Filings	2015-06-25	English
Teva och Active Biotech meddelar att fas III-studien CONCERTO med laquinimod är fullrekryterad Regulatory Filings	2015-06-25	Swedish
Annual General Meeting of Active Biotech AB AGM Information	2015-06-12	English
Årsstämma i Active Biotech AB AGM Information	2015-06-12	Swedish
Active Biotech fokuserar verksamheten på laquinimodprojektet och anpassar organisationen Earnings Release FY 2015	2015-06-01	Swedish
Active Biotech focuses the operations on the laquinimod project and adjusts the organization Management Reports	2015-06-01	English
Kallelse till årsstämma AGM Information	2015-05-12	Swedish
Notice of Annual General Meeting of Shareholders AGM Information	2015-05-12	English
Annual Report 2014 Annual Report FY 2014	2015-04-30	Swedish
Annual Report 2014 Annual Report FY 2014	2015-04-30	English
Annual Report 2014 Active Biotech AB (publ) Report Publication Announcement	2015-04-30	English
Årsredovisning 2014 Active Biotech AB (publ) Report Publication Announcement	2015-04-30	Swedish
Teva och Active Biotech meddelar att första patienten är rekryterad till fas II-studien som utvärderar laquinimod för behandling av primärprogressiv MS Regulatory Filings	2015-04-23	Swedish
Teva and Active Biotech Announce First Patient Enrolled in Phase II Study Evaluating Laquinimod for Primary Progressive MS Regulatory Filings	2015-04-23	English
Interim / Quarterly Report 2015 Interim / Quarterly Report Q1 2015	2015-04-23	Swedish
Interim / Quarterly Report 2015 Interim / Quarterly Report Q1 2015	2015-04-23	English
Active Biotech and Ipsen announce their decision to discontinue the development of tasquinimod in prostate cancer Regulatory Filings	2015-04-16	English
Active Biotech och Ipsen meddelar att utvecklingen av tasquinimod för behandling av prostatacancer avbryts Regulatory Filings	2015-04-16	Swedish
Interim / Quarterly Report 2014 Interim / Quarterly Report FY 2014	2015-02-11	Swedish
Annual Report 2014 Annual Report FY 2014	2015-02-11	English
Active Biotech AB Bokslutsrapport januari - december 2014 Interim / Quarterly Report FY 2014	2015-02-11	Swedish
Active Biotech AB Year-end report January - December 2014 Annual Report FY 2014	2015-02-11	English
Antal aktier och röster i Active Biotech Declaration of Voting Results & Voting Rights Announcements	2015-01-30	Swedish
Number of shares and votes in Active Biotech Declaration of Voting Results & Voting Rights Announcements	2015-01-30	English
Active Biotech presenterar på 33rd Annual J.P. Morgan Healthcare Conference Regulatory Filings	2015-01-12	Swedish
Active Biotech to Present at the 33rd Annual J.P. Morgan Healthcare Conference Report Publication Announcement	2015-01-12	English

Filings by year

2026 11 filings
2025 41 filings
2024 45 filings
2023 32 filings
2022 42 filings
2021 48 filings
2020 41 filings
2019 45 filings
2018 38 filings
2017 33 filings
2016 40 filings
2015 40 filings
2014 49 filings
2013 58 filings
2012 58 filings
2011 56 filings
2010 62 filings
2009 55 filings
2008 28 filings
2007 8 filings